Project Grant K08NS133300
Award Date
8/1/24
Completion Date
6/30/29
Dollars Obligated
$196K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This $1,008,977 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports research to understand human brain development and the origins of neurodevelopmental diseases. The award aims to study two recently discovered neural progenitor cell types found in the outer subventricular zone of the developing human brain, which are key...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,341,874.00 to The Regents of the University of California, San Francisco to conduct research on dendrite development, function, degeneration, and regeneration. The research aims to elucidate the molecular mechanisms controlling dendrite development, investigate the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,174,913 to support research focused on understanding the mechanisms of homeostatic plasticity and its potential role in neuroprotection and resilience to neurological disorders. The award aims to identify positive genetic modulators of homeostatic plasticity, with the...
This $345,114 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports a research initiative to develop novel therapeutic strategies for Huntington's disease (HD) by targeting the MSH3 protein. The project aims to establish a robust screening pipeline utilizing a newly developed mouse model to identify small molecules that can...
This $153,488 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to investigate the mechanisms by which the HSP70 molecular chaperone system interacts with the AAA+ disaggregase HSP104 to target and solubilize toxic amyloid aggregates. The research aims to use biochemical and cryo-EM structural approaches to define the precise interaction between HSP70 and HSP104, and how this...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $136,309 to the University of California, Irvine (UC Irvine) from September 30, 2024 to August 31, 2026. The funding supports research to investigate the role of dysfunctional astrocyte development and maturation in the onset and progression of Huntington's disease (HD)....
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $2,503,949.00 to Rockefeller University to conduct research aimed at discovering new therapeutic targets for neurological diseases. The research focuses on understanding the downstream effects of genetic defects on different cell types...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the mechanisms regulating the folding, trafficking, and degradation of the NPC1 protein in human neurons. The overall objective is to characterize the cellular pathways that control NPC1 proteostasis, with the goal of identifying new targets for...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $941,337 to the University of California, San Diego to conduct research on the regulation of phase separation in neuronal heterochromatin. The research aims to explore the role of the protein Ki-67 in the formation of heterochromatin in neurons, determine how Ki-67...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $2,307,075 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Leland Stanford Junior University (Stanford University) to conduct research aimed at defining novel mechanisms of neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Parkinson's disease, and to translate those findings into potential new...